tiprankstipranks
TG Therapeutics (TGTX)
NASDAQ:TGTX

TG Therapeutics (TGTX) Cash flow

1,535 Followers

TG Therapeutics Cash Flow

TGTX's free cash flow for Q4 2023 was $-13.21M. For the 2023 fiscal year, TGTX's free cash flow was decreased by $144.77M and operating cash flow was $-13.21M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -32.40M$ -31.41M$ -176.17M$ -297.53M$ -214.51M$ -132.81M
Investing Cash Flow
$ -49.66M$ -50.65M$ -20.01M$ 1.56M$ -24.51M$ -718.00K
Financing Cash Flow
$ 72.70M$ 72.70M$ -391.00K$ 41.42M$ 679.83M$ 204.21M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 407.41M$ 94.22M$ 103.58M$ 300.15M$ 554.70M$ 113.89M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 8.77M$ 8.77M--$ 4.50M$ 2.62M
Issuance Of Capital Stock
$ 46.30M$ 46.30M--$ 679.68M$ 175.02M
Issuance Of Debt
$ 25.00M$ 25.00M$ -975.00K$ 40.00M$ 0.00$ 29.99M
Repayment Of Debt
---$ -30.00M$ 0.00-
Free Cash Flow
$ -32.40M$ -31.41M$ -176.18M$ -297.93M$ -214.86M$ -132.94M
Domestic Sales
------
Foreign Sales
------
Currency in USD

TG Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis